The MUC gene family: Their role in the diagnosis and prognosis of gastric cancer

Histology and Histopathology

Volumn 23, Issue 12, 2008, Pages 1541-1552

  Senapati, Shantibhusan ^a   Sharma, Poonam ^b   Bafna, Sangeeta ^a   Roy, Hemant K ^c   Batra, Surinder K ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Diagnosis; Gastric cancer; Mucin; Prognosis

Indexed keywords

CA 125 ANTIGEN; CARBOHYDRATE ANTIGEN; EPITOPE; GLYCOPROTEIN; MUCIN 1; MUCIN 2; MUCIN 3; MUCIN 4; MUCIN 5AC; MUCIN 5B; MUCIN 6; MUCIN 7; MUCIN 8; STOMACH MUCIN; TUMOR MARKER;

CANCER STAGING; CHRONIC GASTRITIS; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; HISTOPATHOLOGY; HUMAN; INTESTINE METAPLASIA; MULTIGENE FAMILY; NONHUMAN; PROGNOSIS; REVIEW; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH DISEASE; ADENOCARCINOMA; GENE EXPRESSION; GENETICS; METABOLISM; STOMACH TUMOR;

ADENOCARCINOMA; GASTRIC MUCINS; GENE EXPRESSION; HUMANS; PROGNOSIS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 58149291766     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (95)

1. Allen A. and Flemstrom G. (2005). Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin. Am. J. Physiol. Cell. Physiol. 288, C1-19.
2. Andersen L.P. (2007). Colonization and infection by Helicobacter pylori in humans. Helicobacter 12 (Suppl 2), 12-15.
3. Andrianifahanana M., Moniaux N. and Batra S.K. (2006). Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases. Biochim. Biophys. Acta 1765, 189-222.
4. Babu S.D., Jayanthi V., Devaraj N., Reis C.A. and Devaraj H. (2006). Expression profile of mucins (MUC2, MUC5AC and MUC6) in Helicobacter pylori infected pre-neoplastic and neoplastic human gastric epithelium. Mol. Cancer 5, 10.
5. Bai Y.Q., Yamamoto H., Akiyama Y., Tanaka H., Takizawa T., Koike M., Kenji Yagi O., Saitoh K., Takeshita K., Iwai T. and Yuasa Y. (2002). Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach. Cancer Lett. 176, 47-55.
6. Bobek L.A., Tsai H., Biesbrock A.R. and Levine M.J. (1993). Molecular cloning, sequence, and specificity of expression of the gene encoding the low molecular weight human salivary mucin (MUC7). J. Biol. Chem. 268, 20563-20569.
7. Braga V.M., Pemberton L.F., Duhig T. and Gendler S.J. (1992). Spatial and temporal expression of an epithelial mucin, Muc-1, during mouse development. Development 115, 427-437.
8. Brockhausen I., Moller G., Merz G., Adermann K. and Paulsen H. (1990). Control of mucin synthesis: the peptide portion of synthetic O-glycopeptide substrates influences the activity of O-glycan core 1 UDPgalactose:N-acetyl-alpha-galactosaminyl-R beta 3-galactosyltransferase. Biochemistry 29, 10206-10212.
9. Buisine M.P., Devisme L., Maunoury V., Deschodt E., Gosselin B., Copin M.C., Aubert J.P. and Porchet N. (2000). Developmental mucin gene expression in the gastroduodenal tract and accessory digestive glands. I. Stomach. A relationship to gastric carcinoma. J. Histochem. Cytochem. 48, 1657-1666.
10. Burchell J., Gendler S., Taylor-Papadimitriou J., Girling A., Lewis A., Millis R. and Lamport D. (1987). Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. Cancer Res. 47, 5476-5482.
11. Byrd J.C., Yan P., Sternberg L., Yunker C.K., Scheiman J.M. and Bresalier R.S. (1997). Aberrant expression of gland-type gastric mucin in the surface epithelium of Helicobacter pylori-infected patients. Gastroenterology 113, 455-464.
12. Byrd J.C., Yunker C.K., Xu Q.S., Sternberg L.R. and Bresalier R.S. (2000). Inhibition of gastric mucin synthesis by Helicobacter pylori. Gastroenterology 118, 1072-1079.
13. Carrato C., Balague C., de Bolos C., Gonzalez E., Gambus G., Planas J., Perini J.M., Andreu D. and Real F.X. (1994). Differential apomucin expression in normal and neoplastic human gastrointestinal tissues. Gastroenterology 107, 160-172.
14. Censini S., Lange C., Xiang Z., Crabtree J.E., Ghiara P., Borodovsky M., Rappuoli R. and Covacci A. (1996). cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl. Acad. Sci. USA 93, 14648-14653.
15. Corfield A.P., Myerscough N., Gough M., Brockhausen I., Schauer R. and Paraskeva C. (1995). Glycosylation patterns of mucins in colonic disease. Biochem. Soc. Trans. 23, 840-845.
16. Corfield A.P., Myerscough N., Longman R., Sylvester P., Arul S. and Pignatelli M. (2000). Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease. Gut 47, 589-594.
17. Correa P. (1988). A human model of gastric carcinogenesis. Cancer Res. 48, 3554-3560.
18. Correa P. (1992a). Diet modification and gastric cancer prevention. J. Natl. Cancer Inst. Monogr. 75-78.
19. Correa P. (1992b). Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 52, 6735-6740
20. Correa P. and Houghton J. (2007). Carcinogenesis of Helicobacter pylori. Gastroenterology 133, 659-672..
21. Correa P. and Shiao Y.H. (1994). Phenotypic and genotypic events in gastric carcinogenesis. Cancer Res. 54, 1941s-1943s.
22. de Bolos C., Garrido M. and Real F.X. (1995). MUC6 apomucin shows a distinct normal tissue distribution that correlates with Lewis antigen expression in the human stomach. Gastroenterology 109, 723-734.
23. Devine P.L. and McKenzie I.F. (1992). Mucins: structure, function, and associations with malignancy. Bioessays 14, 619-625.
24. Feng C.W., Wang L.D., Jiao L.H., Liu B., Zheng S. and Xie X.J. (2002). Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features. BMC Cancer 2, 8.
25. Filipe M.I. (1979). Mucins in the human gastrointestinal epithelium: a review. Invest. Cell Pathol. 2, 195-216.
26. Filipe M.I., Barbatis C., Sandey A. and Ma J. (1988). Expression of intestinal mucin antigens in the gastric epithelium and its relationship with malignancy. Human Pathol. 19, 19-26.
27. Fiocca R., Villani L., Tenti P., Solcia E., Cornaggia M., Frigerio B. and Capella C. (1987). Characterization of four main cell types in gastric cancer: foveolar, mucopeptic, intestinal columnar and goblet cells. An histopathologic, histochemical and ultrastructural study of "early" and "advanced" tumours. Pathol. Res. Pract. 182, 308-325
28. Fiocca R., Villani L., Tenti P., Cornaggia M., Finzi G., Capella C., Prat M., Bussolati G. and Solcia E. (1988). Widespread expression of intestinal markers in gastric carcinoma: a light and electron microscopic study using BD-5 monoclonal antibody. J. Clin. Pathol. 41, 178-187.
29. Gendler S.J. and Spicer A.P. (1995). Epithelial mucin genes. Annu. Rev. Physiol. 57, 607-634
30. Girling A., Bartkova J., Burchell J., Gendler S., Gillett C. and Taylor-Papadimitriou J. (1989). A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas. Int. J. Cancer 43, 1072-1076
31. Griffiths B., Matthews D.J., West L., Attwood J., Povey S., Swallow D.M., Gum J.R. and Kim Y.S. (1990). Assignment of the polymorphic intestinal mucin gene (MUC2) to chromosome 11p15. Ann. Hum. Genet. 54, 277-285
32. Gum J.R. Jr. (1992). Mucin genes and the proteins they encode: structure, diversity, and regulation. Am. J. Respir. Cell Mol. Biol. 7, 557-564.
33. Halliwell B. (2007). Oxidative stress and cancer: have we moved forward? Biochem. J. 401, 1-11.
34. Hansson L.E., Nyren O., Hsing A.W., Bergstrom R., Josefsson S., Chow W.H., Fraumeni J.F. Jr. and Adami H.O. (1996). The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N. Engl. J Med. 335, 242-249.
35. Ho S.B., Niehans G.A., Lyftogt C., Yan P.S., Cherwitz D.L., Gum E.T., Dahiya R. and Kim Y.S. (1993). Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res. 53, 641-651.
36. Ho S.B., Roberton A.M., Shekels L.L., Lyftogt C.T., Niehans G.A. and Toribara N.W. (1995a). Expression cloning of gastric mucin complementary DNA and localization of mucin gene expression. Gastroenterology 109, 735-747.
37. Ho S.B., Shekels L.L., Toribara N.W., Kim Y.S., Lyftogt C., Cherwitz D.L. and Niehans G.A. (1995b). Mucin gene expression in normal, preneoplastic, and neoplastic human gastric epithelium. Cancer Res. 55, 2681-2690.
38. Hollingsworth M.A. and Swanson B.J. (2004). Mucins in cancer: protection and control of the cell surface. Nat. Rev. Cancer 4, 45-60.
39. Howson C.P., Hiyama T. and Wynder E.L. (1986). The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol. Rev. 8, 1-27.
40. Jass J.R. (2000). Mucin core proteins as differentiation markers in the gastrointestinal tract. Histopathology 37, 561-564.
41. Kabashima A., Yao T., Sugimachi K. and Tsuneyoshi M. (2000). Gastric or intestinal phenotypic expression in the carcinomas and background mucosa of multiple early gastric carcinomas. Histopathology 37, 513-522
42. Kawachi H., Takizawa T., Eishi Y., Shimizu S., Kumagai J., Funata N. and Koike M. (2003). Absence of either gastric or intestinal phenotype in microscopic differentiated gastric carcinomas. J. Pathol. 199, 436-446
43. Kawasaki H., Morishige F., Tanaka H. and Kimoto E. (1982). Influence of oral supplementation of ascorbate upon the induction of N-methyl-N'-nitro-N-nitrosoguanidine. Cancer Lett. 16, 57-63
44. Kim Y.S. and Gum J.R. Jr. (1995). Diversity of mucin genes, structure, function, and expression. Gastroenterology 109, 999-1001
45. Kocer B., Ulas M., Ustundag Y., Erdogan S., Karabeyoglu M., Yldrm O., Unal B., Cengiz O. and Soran A. (2004). A confirmatory report for the close interaction of Helicobacter pylori with gastric epithelial MUC5AC expression. J. Clin. Gastroenterol. 38, 496-502
46. Koh T.J., Goldenring J.R., Ito S., Mashimo H., Kopin A.S., Varro A., Dockray G.J. and Wang T.C. (1997). Gastrin deficiency results in altered gastric differentiation and decreased colonic proliferation in mice. Gastroenterology 113, 1015-1025.
47. Lauren P. (1965). The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. an attempt at a histo-clinical classification. Acta Pathol. Microbiol. Scand. 64, 31-49.
48. Leteurtre E., Zerimech F., Piessen G., Wacrenier A., Leroy X., Copin M.C., Mariette C., Aubert J.P., Porchet N. and Buisine M.P. (2006). Relationships between mucinous gastric carcinoma, MUC2 expression and survival. World J. Gastroenterol. 12, 3324-3331.
49. Li L., Zhang S., Lin H. and Lin J.Y. (2002). [Relationship of expression unbalance of matrix metalloproteinase and tissue inhibitor of metalloproteinase to invasiveness and metastasis in gastric carcinomas]. Ai Zheng 21, 305-310.
50. Ma M.S., Hwang J.S., Na S.I., Lee K.H., Choi J.K., Lee S.O., Kang M.J., Kim D.G., Ahn D.S. and Lee S.T. (2003). The change of gastric antral mucin expression after Helicobacter pylori eradication. Korean J. Med. 64, 21-27.
51. Machado J.C., Nogueira A.M., Carneiro F., Reis C.A. and Sobrinho-Simoes M. (2000). Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6). J. Pathol. 190, 437-443.
52. Makiguchi Y., Hinoda Y. and Imai K. (1996). Effect of MUC1 mucin, an anti-adhesion molecule, on tumor cell growth. Jpn. J. Cancer Res. 87, 505-511.
53. Mannick E.E., Bravo L.E., Zarama G., Realpe J.L., Zhang X.J., Ruiz B., Fontham E.T., Mera R., Miller M.J. and Correa P. (1996). Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res. 56, 3238-3243.
54. Mesquita P., Jonckheere N., Almeida R., Ducourouble M.P., Serpa J., Silva E., Pigny P., Silva F.S., Reis C., Silberg D., Van Seuningen I. and David L. (2003). Human MUC2 mucin gene is transcriptionally regulated by Cdx homeodomain proteins in gastrointestinal carcinoma cell lines. J. Biol. Chem. 278, 51549-51556.
55. Mingchao, Devereux T.R., Stockton P., Sun K., Sills R.C., Clayton N., Portier M. and Flake G. (2001). Loss of E-cadherin expression in gastric intestinal metaplasia and later stage p53 altered expression in gastric carcinogenesis. Exp. Toxicol. Pathol. 53, 237-246.
56. Mino-Kenudson M., Tomita S. and Lauwers G.Y. (2007). Mucin expression in reactive gastropathy: an immunohistochemical analysis. Arch. Pathol. Lab. Med. 131, 86-90.
57. Moniaux N., Escande F., Porchet N., Aubert J.P. and Batra S.K. (2001). Structural organization and classification of the human mucin genes. Front. Biosci. 6, D1192-D1206.
58. Motoshita J., Nakayama H., Taniyama K., Matsusaki K. and Yasui W. (2006). Molecular characteristics of differentiated-type gastric carcinoma with distinct mucin phenotype: LI-cadherin is associated with intestinal phenotype. Pathol. Int. 56, 200-205.
59. Murata K., Egami H., Shibata Y., Sakamoto K., Misumi A. and Ogawa M. (1992). Expression of blood group-related antigens, ABH, Lewis(a), Lewis(b), Lewis(x), Lewis(y), CA19-9, and CSLEX1 in early cancer, intestinal metaplasia, and uninvolved mucosa of the stomach. Am. J. Clin. Pathol. 98, 67-75.
60. Nakagawa K., Akagi J., Takai E., Tamori Y., Okino T., Kako H., Egami H. and Ogawa M. (1999). Prognostic values of MUC-1 molecule expressing cytokine receptor-like epitope and DF3 in patients with gastric carcinoma. Int. J. Oncol. 14, 425-435.
61. Nakamura K., Sugano H. and Takagi K. (1968). Carcinoma of the stomach in incipient phase: its histogenesis and histological appearances. Gann 59, 251-258.
62. Nardelli J., Loridon-Rosa B., Bara J. and Burtin P. (1984). Fetal gastric and small intestine pattern of intestinal mucus antigens in human gastric carcinomas. Cancer Res. 44, 4157-4163.
63. Nogueira A.M., Machado J.C., Carneiro F., Reis C.A., Gott P. and Sobrinho-Simoes M. (1999). Patterns of expression of trefoil peptides and mucins in gastric polyps with and without malignant transformation. J. Pathol. 187, 541-548.
64. Nordman H., Davies J.R., Lindell G. and Carlstedt I. (1995). Human gastric mucins - a major population identified as MUC5. Biochem. Soc. Trans. 23, 533S.
65. Ohno T., Aihara R., Kamiyama Y., Mochiki E., Asao T. and Kuwano H. (2006). Prognostic significance of combined expression of MUC1 and adhesion molecules in advanced gastric cancer. Eur. J. Cancer 42, 256-263.
66. Ota H., Nakayama J., Momose M., Hayama M., Akamatsu T., Katsuyama T., Graham D.Y. and Genta R.M. (1998). Helicobacter pylori infection produces reversible glycosylation changes to gastric mucins. Virchows Arch. 433, 419-426.
67. Paulson J.C., Weinstein J. and Schauer A. (1989). Tissue-specific expression of sialyltransferases. J. Biol. Chem. 264, 10931-10934.
68. Pinto-de-Sousa J., David L., Reis C.A., Gomes R., Silva L. and Pimenta A. (2002). Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma. Virchows Arch. 440, 304-310.
69. Reis C.A., David L., Correa P., Carneiro F., de Bolos C., Garcia E., Mandel U., Clausen H. and Sobrinho-Simoes M. (1999). Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res. 59, 1003-1007.
70. Reis C.A., David L., Nielsen P.A., Clausen H., Mirgorodskaya K., Roepstorff P. and Sobrinho-Simoes M. (1997). Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody. International journal of cancer. J. Int. Cancer 74, 112-121.
71. Reis C.A., David L., Seixas M., Burchell J. and Sobrinho-Simoes M. (1998). Expression of fully and under-glycosylated forms of MUC1 mucin in gastric carcinoma. International journal of cancer. J. Int. Cancer 79, 402-410.
72. Rhyu M.G., Park W.S. and Meltzer S.J. (1994). Microsatellite instability occurs frequently in human gastric carcinoma. Oncogene 9, 29-32
73. Rokkas T., Filipe M.I. and Sladen G.E. (1991). Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up. Gut 32, 1110-1113.
74. Ross J.S. and McKenna B.J. (2001). The HER-2/neu oncogene in tumors of the gastrointestinal tract. Cancer Invest. 19, 554-568.
75. Sepulveda A.R., Wu L., Ota H., Gutierrez O., Kim J.G., Genta R.M. and Graham D.Y. (2000). Molecular identification of main cellular lineages as a tool for the classification of gastric cancer. Human Pathol. 31, 566-574.
76. Shimamura T., Ito H., Shibahara J., Watanabe A., Hippo Y., Taniguchi H., Chen Y., Kashima T., Ohtomo T., Tanioka F., Iwanari H., Kodama T., Kazui T., Sugimura H., Fukayama M. and Aburatani H. (2005). Overexpression of MUC13 is associated with intestinal-type gastric cancer. Cancer Sci. 96, 265-273.
77. Sidebotham R.L., Dhir N.K., Elder J.B., Spencer J., Walker M.M. and Schrager J. (1998). Changes to mucins in uninvolved mucosa and at the tumour site in gastric adenocarcinoma of intestinal type. Clin. Sci. (Lond) 94, 87-99.
78. Silberg D.G., Sullivan J., Kang E., Swain G.P., Moffett J., Sund N.J., Sackett S.D. and Kaestner K.H. (2002). Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology 122, 689-696.
79. Slomiany B.L. and Slomiany A. (1992). Mechanism of Helicobacter pylori pathogenesis: focus on mucus. J. Clin. Gastroenterol. 14 Suppl 1, S114-S121.
80. Steininger H., Pfofe D.A., Muller H., Haag-Sunjic G. and Fratianu V. (2005). Expression of CDX2 and MUC2 in Barrett's mucosa. Pathol. Res. Pract. 201, 573-577.
81. Suda Y., Kuwashima Y., Tanaka Y., Uchida K. and Akazawa S. (1999). Immunohistochemical detection of thymidylate synthase in advanced gastric cancer: a prognostic indicator in patients undergoing gastrectomy followed by adjuvant chemotherapy with 5-fluoropyrimidines. Anticancer Res. 19, 805-810.
82. Tanaka M., Kitajima Y., Sato S. and Miyazaki K. (2003). Combined evaluation of mucin antigen and E-cadherin expression may help select patients with gastric cancer suitable for minimally invasive therapy. Br. J. Surg. 90, 95-101.
83. Tasman-Jones C. (1985). Gastric mucus - physical properties in cytoprotection. Med. J. Aust. 142, S5-S6.
84. Uemura N., Okamoto S., Yamamoto S., Matsumura N., Yamaguchi S., Yamakido M., Taniyama K., Sasaki N. and Schlemper R.J. (2001). Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 345, 784-789.
85. Utsunomiya T., Yonezawa S., Sakamoto H., Kitamura H., Hokita S., Aiko T., Tanaka S., Irimura T., Kim Y.S. and Sato E. (1998). Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. Clin. Cancer Res. 4, 2605-2614.
86. Van den Brink G.R., Tytgat K.M., Van der Hulst R.W., Van der Loos C.M., Einerhand A.W., Buller H.A. and Dekker J. (2000). H. pylori colocalises with MUC5AC in the human stomach. Gut 46, 601-607.
87. Walker M.M., Smolka A., Waller J.M. and Evans D.J. (1995). Identification of parietal cells in gastric body mucosa with HMFG-2 monoclonal antibody. J. Clin. Pathol. 48, 832-834.
88. Wang R.Q. and Fang D.C. (2006). Effects of Helicobacter pylori infection on mucin expression in gastric carcinoma and pericancerous tissues. J. Gastroenterol. Hepatol. 21, 425-431.
89. Werther J.L., Tatematsu M., Klein R., Kurihara M., Kumagai K., Llorens P., Guidugli Neto J., Bodian C., Pertsemlidis D., Yamachika T., Kitou T. and Itzkowitz S. (1996). Sialosyl-Tn antigen as a marker of gastric cancer progression: an international study. Int. J. Cancer 69, 193-199.
90. Williams S.J., Wreschner D.H., Tran M., Eyre H.J., Sutherland G.R. and McGuckin M.A. (2001). Muc13, a novel human cell surface mucin expressed by epithelial and hemopoietic cells. J. Biol. Chem. 276, 18327-18336.
91. Wong B.C., Lam S.K., Wong W.M., Chen J.S., Zheng T.T., Feng R.E., Lai K.C., Hu W.H., Yuen S.T., Leung S.Y., Fong D.Y., Ho J., Ching C.K. and Chen J.S. (2004). Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 291, 187-194.
92. Xue Y.W., Zhang Q.F., Zhu Z.B., Wang Q. and Fu S.B. (2003). Expression of cyclooxygenase-2 and clinicopathologic features in human gastric adenocarcinoma. World J. Gastroenterol. 9, 250-253.
93. Yamamoto H., Bai Y.Q. and Yuasa Y. (2003). Homeodomain protein CDX2 regulates goblet-specific MUC2 gene expression. Biochem. Biophys. Res. Commun. 300, 813-818.
94. Zhang C., Yamada N., Wu Y.L., Wen M., Matsuhisa T. and Matsukura N. (2005). Helicobacter pylori infection, glandular atrophy and intestinal metaplasia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer and early gastric cancer. World J. Gastroenterol. 11, 791-796.
95. Zhang H., Wu J., Meng L. and Shou C.C. (2002). Expression of vascular endothelial growth factor and its receptors KDR and Flt-1 in gastric cancer cells. World J. Gastroenterol. 8, 994-998.